Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

Imagem de Miniatura
Arquivos
art_BOUSQUET_Scaling_up_strategies_of_the_chronic_respiratory_disease_2016.PDF (1.25 MB)
Citações na Scopus
46
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
BOUSQUET, J.
FARRELL, J.
CROOKS, G.
HELLINGS, P.
BEL, E. H.
BEWICK, M.
CHAVANNES, N. H.
SOUSA, J. Correia de
CRUZ, A. A.
HAAHTELA, T.
Citação
CLINICAL AND TRANSLATIONAL ALLERGY, v.6, article ID 29, 18p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un Vleillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
Palavras-chave
EIP on AHA, European Innovation Partnership on Active and Healthy Ageing, Chronic respiratory diseases, AIRWAYS ICPs, MACVIA, ARIA, Scaling up
URI
https://observatorio.fm.usp.br/handle/OPI/19087
Referências
  1. Agache Ioana, 2009, Pneumologia, V58, P255
  2. Bachert C, 2008, B-ENT, V4, P253
  3. Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
  4. Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9
  5. Blain H, 2014, EUR GERIATR MED, V5, P416, DOI 10.1016/j.eurger.2014.07.010
  6. Boulet LP, 2012, EUR RESPIR J, V39, P1220, DOI 10.1183/09031936.00184511
  7. Bourret Rodolphe, 2015, World Hosp Health Serv, V51, P36
  8. Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x
  9. Bousquet J, 2008, ALLERGY, V63, P631, DOI 10.1111/j.1398-9995.2008.01730.x
  10. Bousquet J, 2007, ALLERGY, V62, P216, DOI 10.1111/j.1398-9995.2007.01307.x
  11. Bousquet J, 2006, REV MAL RESPIR, V23, pS73, DOI 10.1019/20064092
  12. Bousquet J, 2016, REV PORT PNEUMOL, V22, P1, DOI 10.1016/j.rppnen.2015.12.006
  13. Bousquet J, 2015, J NUTR HEALTH AGING, V19, P955, DOI 10.1007/s12603-015-0589-6
  14. Bousquet J, 2015, ALLERGY, V70, P1372, DOI 10.1111/all.12686
  15. Bousquet J, 2015, REV PORT PNEUMOL, V21, P230, DOI 10.1016/j.rppnen.2015.07.001
  16. Bousquet J, 2015, ALLERGY, V70, P1062, DOI 10.1111/all.12637
  17. Bousquet J, 2015, EUR GERIATR MED, V6, P293, DOI 10.1016/j.eurger.2015.01.010
  18. Bousquet J, 2015, THORAX, V70, P595, DOI 10.1136/thoraxjnl-2014-206304
  19. Bousquet J, 2015, EUR GERIATR MED, V6, P196, DOI 10.1016/j.eurger.2014.12.006
  20. Bousquet J, 2014, EUR GERIATR MED, V5, P406, DOI 10.1016/j.eurger.2014.0.013
  21. Bousquet J, 2014, EUR GERIATR MED, V5, P361, DOI 10.1016/j.eurger.2014.09.010
  22. Bousquet J, 2014, EUR RESPIR J, V44, P304, DOI 10.1183/09031936.00014614
  23. Bousquet J, 2013, ALLERGY, V68, P555, DOI 10.1111/all.12115
  24. Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053
  25. Bousquet J, 2012, INT ARCH ALLERGY IMM, V158, P216, DOI 10.1159/000332924
  26. Bousquet J, 2011, ALLERGY, V66, P765, DOI 10.1111/j.1398-9995.2011.02590.x
  27. Bousquet J, 2011, ALLERGY, V66, P596, DOI 10.1111/j.1398-9995.2010.02534.x
  28. Bousquet J, 2010, EUR RESPIR J, V36, P995, DOI 10.1183/09031936.00012610
  29. Bousquet J, 2010, ALLERGY, V65, P1212, DOI 10.1111/j.1398-9995.2010.02480.x
  30. Bousquet J, 2009, ALLERGY, V64, P969, DOI 10.1111/j.1398-9995.2009.02059.x
  31. Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891
  32. Bousquet J, 2007, GLOBAL SURVEILLANCE
  33. Bousquet J, 2016, EUR RESPIR J, V47, P1028, DOI 10.1183/13993003.01856-2015
  34. Bousquet J, 2015, J AM MED DIR ASSOC, V16, P1020, DOI 10.1016/j.jamda.2015.09.004
  35. Bousquet J, 2015, EUR RESPIR J, V46, P579, DOI 10.1183/13993003.01084-2015
  36. Bousquet J, 2015, J THORAC DIS, V7, P108, DOI 10.3978/j.issn.2072-1439.2014.11.11
  37. Bousquet J, 2014, CURR PHARM DESIGN, V20, P5928, DOI 10.2174/1381612820666140314115505
  38. Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019
  39. Briggs R, 2015, EUR GERIATR MED, V6, P401
  40. Brozek JL, 2008, ALLERGY, V63, P38, DOI 10.1111/j.1398-9995.2007.01560.x
  41. Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x
  42. Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047
  43. Cagnani Carlos E Baena, 2009, Rev Alerg Mex, V56, P56
  44. Canonica GW, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0079-7
  45. Carlsen KCL, 2015, INT ARCH ALLERGY IMM, V167, P57, DOI 10.1159/000431359
  46. Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013
  47. Council Europa, 2013, COUNC CONCL REFL PRO
  48. Cruz AA, 2009, ALLERGY, V64, P319, DOI 10.1111/j.1398-9995.2009.02026.x
  49. Cruz Alvaro A, 2010, World Allergy Organ J, V3, P167, DOI 10.1097/WOX.0b013e3181dc3383
  50. Manuel-Keenoy de- E, 2014, EUR GERIATR MED, V5, P342
  51. Fairall L, 2015, BMJ INNOV, V1, P196, DOI 10.1136/BMJINNOV-2015-000045
  52. Fischer Gilberto Bueno, 2005, Paediatr Respir Rev, V6, P8, DOI 10.1016/j.prrv.2004.11.002
  53. Fokkens W, 2007, RHINOL S, V2007, P1
  54. Franco R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-82
  55. Global Alliance against Chronic Respiratory Diseases (GARD), 2014, 9 GEN M 14 16 AUG 20
  56. Global Alliance against Chronic Respiratory Diseases (GARD), 2015, 10 GEN M 1 2 JUL 201
  57. Glacy J, 2013, AHRQ COMP EFFECTIVEN
  58. Glaser E, 1983, PUTTING KNOWLEDGE US
  59. Grimaldo F, 2014, INT J ARTIF INTELL T, V23, DOI 10.1142/S0218213014400053
  60. Haahtela T, 2008, ALLERGY, V63, P634, DOI 10.1111/j.1398-9995.2008.01712.x
  61. Haahtela T, 2006, THORAX, V61, P663, DOI 10.1136/thx.2005.055699
  62. Haahtela T, 2001, THORAX, V56, P806, DOI 10.1136/thorax.56.10.806
  63. Hartmann A, 2008, SCALING FRAMEWORK LE
  64. Kalayci O, 2008, TURKISH J PEDIATR, V50, P307
  65. Kinnula VL, 2011, PRIM CARE RESP J, V20, P178, DOI 10.4104/pcrj.2011.00024
  66. Kupczyk M, 2010, ALLERGY, V65, P415, DOI 10.1111/j.1398-9995.2009.02265.x
  67. Laurendi G, 2012, RESP MED, V106, P1, DOI 10.1016/j.rmed.2011.10.002
  68. Malva JO, 2016, MATURITAS, V84, P3, DOI 10.1016/j.maturitas.2015.11.004
  69. Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x
  70. Morais-Almeida M, 2013, ALLERGY, V68, P1278, DOI 10.1111/all.12221
  71. Morais-Almeida M, 2013, ALLERGY, V68, P1150, DOI 10.1111/all.12207
  72. Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327
  73. Muraro A, 2015, RHINOLOGY
  74. Muraro A, 2015, ALLERGY
  75. Nogues M, 2015, PRESSE MED S1, V44, pS6
  76. O'Caoimh R., 2015, EURO GERIATR MED, V6, P505, DOI 10.1159/000433432
  77. Padjas A, 2014, J ALLERGY CLIN IMMUN, V133, P777, DOI 10.1016/j.jaci.2013.08.029
  78. Pali-Scholl Isabella, 2009, Wien Med Wochenschr, V159, P87, DOI 10.1007/s10354-009-0646-z
  79. Pawankar R, 2009, ASIAN PAC J ALLERGY, V27, P237
  80. [Anonymous], 2012, PORT NAT PROGR RESP
  81. Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015
  82. Reddel HK, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.50
  83. Rose L, 2012, CAN RESPIR J, V19, P216
  84. Samolinski B, 2012, ALLERGY, V67, P726, DOI 10.1111/j.1398-9995.2012.02822.x
  85. Samolinski B, 2012, LANCET, V379, pE45, DOI 10.1016/S0140-6736(12)60514-5
  86. Samolinski B, 2015, EUR GERIATR MED, V6, P389
  87. Sanna Liuska, 2010, J Ambul Care Manage, V33, P265, DOI 10.1097/JAC.0b013e3181e5eb7b
  88. Selroos Olof, 2015, Eur Respir Rev, V24, P474, DOI 10.1183/16000617.00008114
  89. Souza-Machado C, 2010, EUR RESPIR J, V35, P515, DOI 10.1183/09031936.00101009
  90. UVIN P, 1995, WORLD DEV, V23, P927, DOI 10.1016/0305-750X(95)00028-B
  91. Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP
  92. Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034
  93. World Health Organization, 2010, PACK ESS NONC PEN DI
  94. Wilson N, 2015, EUR GERIATR MED, V6, P396, DOI 10.1016/j.eurger.2015.03.008
  95. Yorgancioglu A, 2012, Tuberk Toraks, V60, P92
  96. Yorgancioglu A, 2010, Tuberk Toraks, V58, P213
  97. Yorgancioglu A, 2009, Tuberk Toraks, V57, P439
  98. Yorgancioglu A, 2014, PRIM CARE RESP J, V23, P98, DOI 10.4104/pcrj.2014.00014
  99. Zhang H, 2014, LANCET RESP MED, V2, P785, DOI 10.1016/S2213-2600(14)70188-2

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/09
Artigos e Materiais de Revistas Científicas - ODS/03